$1.92
0.15.49%
At close: Sep 4, 5:00 PM EST
$1.92
0.15.49%
Pre-Market: 3:00 AM EST
enGene Therapeutics Inc
ENGNNASDAQ
Earnings: Q3 2026 Earnings were released on Tue Sep 8th, before the market open
enGene Therapeutics Ownership & Insider Activity
enGene Therapeutics (ENGN) institutional and insider ownership, recent insider transactions and ownership breakdown.
Insiders own 4.8% of shares outstanding. Institutional investors hold 0.5%.
Shares Outstanding
67.016M
Shares Float
54.401M
Insider Shares Owned
3.208M
Insider % Owned
4.8%
Institutional Shares Held
346.455K
Institutional % Held
0.5%
Ownership Breakdown
Net Insider Activity by Month
enGene Therapeutics Insider Transactions (Last 6 Months)
No insider filings in the last 6 months.
